The global competent cells market is expected to reach USD 2.1 Billion by the end of 2022, registering double-digit growth at 11.1% CAGR during the forecast period (2022 to 2032). Sales in the market are expected to reach a valuation of ~USD 5.9 Billion by 2032. In terms of product type, chemically competent cells led the market with a share of about 67.8% in 2021.
Competent cells are bacterial cells that can utilize foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E. coli are changed, the cells tend to absorb the DNA. Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development.
| Attributes | Key Insights |
|---|---|
| Competent Cells Market Value 2021 | USD 1.9 Billion |
| Estimated Market Size 2022 | USD 2.1 Billion |
| Projected Market Value 2032 | USD 5.9 Billion |
| CAGR 2022 to 2032 | 11.1% |
| Market Share of Top 5 Countries | 57.4% |
Cloning is expected to expand significantly in the application area due to the growing demand for molecularly cloned items. The cloning sector has benefited from COVID-19 as a result of corporations investing more money in research and development. Furthermore, it is anticipated that the segment would develop faster because of increased cloning research and financial assistance from a number of organizations.
Techniques for cell engineering, such as somatic cell nuclear transfer (SCNT), have demonstrated a variety of uses, including the creation of transgenic animals, the preservation of endangered species, and therapeutic cloning. Since competent cells may be employed in therapeutic cloning research, these fields are anticipated to experience renewed attention, which will lead to an increase in demand for these cells.
Due to rising Research and Development expenditures and the commercialization of proteomics and genomics-based goods, the biotechnology sector is also anticipated to see a significant growth rate. The need for cutting-edge product advancements in the treatment of different ailments is also anticipated to support the segment's expansion. Additionally, it is projected that increased investment in research into DNA cloning methods at academic research facilities and the usage of these products in therapies will accelerate market growth in the near future.
During the projected period, it is predicted that the Asia-Pacific market would account for a large portion of the worldwide competent cells market. Extensive research on DNA cloning methods in the area and the existence of significant market participants are credited with the expansion.
For instance, Takara Bio Inc. stated in January 2021 that its new facility, the Center for Gene and Cell Processing II, for manufacturing and research purposes, had been completed in Shiga, Japan.
China is expected to develop at a profitable CAGR of 10.1% throughout the projected period and will hold a market share of around 54.2% in East Asia in 2021. The competent cells market will grow as research funding and activity increase.
For instance, the State Key Laboratory of Microbial Application, the Natural Science Foundation of China, and SDU's Qilu Youth Scholar Start-up Funding all provided funding for a research study on Escherichia coli BW25113 competent cells made using a straightforward chemical method that has unparalleled transformation and cloning efficiencies in 2022.
Another regional company, HiMedia Solutions, is situated in India and produces a wide range of goods for the market for competent cells. The HiPurA BL21(DE3) Competent Cells, Bacterial Transformation Kit, HiPurA XL1-Blue Competent Cells, and HiPurA Competent Cells are its four main items for this market. The business is India's top producer of trustworthy cells. Its goods made cloning experiments simpler, such as the HiPurA Competent Cells, which were the first competent DH5a cells marketed on the Indian market. The existence of such businesses is probably going to benefit market growth.
Competent cells are bacterial cells, which can utilize foreign DNA from their surroundings through a process known as transformation. Griffith described it initially in Streptococcus pneumoniae. If the cell walls of E.coli are changed, the cells have a greater tendency to absorb the DNA.
Calcium chloride and temperature shock therapy can make the cells competent. Rapidly growing cells can be rendered more competent than cells at other phases of development. Following transformation, the cells may express the acquired genetic information.
As per Future Market Insights (FMI), the competent cells market was approximately 12.8% of the overall USD 14.5 Billion global cell expansion market in 2021. Overall sales of competent cells expanded at a CAGR of 9.9% from 2017 to 2021, on the back of the rising expansion of the healthcare industry.
Increasing adoption of molecular cloned products, recombinant proteins, advancement in molecular cloning research and development with the emergence of new technologies, and numerous government initiatives and government grants available for life science research are the key factors driving industry growth during the forecast period.
Gene therapy can potentially treat a wide range of ailments. The increasing prevalence of cancer, cardiovascular diseases, cystic fibrosis, blood disorders, and immunocompromised cases is rising, which will boost the market in the forecast period. Gene therapy attempts to cure an ailment or enhance your body's capacity to fight disease by replacing a malfunctioning gene or introducing a new gene.
According to World Health Organization (WHO) 2022, cancer is the largest cause of mortality around the globe, accounting for over 10 million deaths in 2020, or roughly one in every six. Colon, lung, breast, rectum, and prostate cancers are the most prevalent. Tobacco use, obesity, alcohol consumption, a lack of consumption of fruits and vegetables, and an insufficient level of physical activity account for almost one-third of cancer fatalities.
In addition, cystic fibrosis is a widespread hereditary condition throughout the white population in the USA. The condition affects one in every 2,500 to 3,500 white babies. Cystic fibrosis affects around one in every 17,000 African Americans and 31,000 Asian Americans, as stated by MedlinePlus in 2021. These conditions require gene therapy, which will positively impact the competent cells market. Backed by these aforementioned factors, the global competent cells market is expected to grow at a CAGR of 11.1% during the forecast period.
Favorable Government Initiatives for Gene Therapy Products to Push the Sales
Growth in the market is predicted to surge on the back of favourable initiatives by governments in emerging countries, increasing FDA approval for gene therapy products, and advancements in research and developmental activities. These factors will boost the demand for better technologies, creating a conducive environment in the competent cells market.
Recombinant DNA technology is one of the most commonly used techniques in introducing a specific gene or a healthy gene into a vector. These vectors can be plasmodial, viral, or nanostructured; the latter is the most commonly used because of its efficacy in colonizing cells and incorporating their genetic material.
Recent advances in recombinant DNA synthesis have enabled the effective production of recombinant proteins at industrial sizes with higher yields and lower production costs. This has enabled the development of new treatments, vaccines, and diagnostic reagents.
Certain nutrients are allowed to clone human genes, which reduces the likelihood of unfavourable immune system reactions in patients, allows for the creation of highly specialized, functional, and active proteins, increases productivity and cost-effectiveness, and reduces the possibility of unknown pathogen transmission from animals or humans.
The rising costs of research and developmental activities and stringent regulations in the field might hamper the growth in the forecast period. Competent cells are utilized in molecular cloning procedures, protein expression, and various plasmid DNA-based applications.
However, depending on the transformation method, for instance, developing the E. coli competent cells can be time-consuming, needing exceptionally pure water, high-grade reagents, specified autoclaved glassware, and or even specialized equipment (electroporators).
Numerous protocols available describe the technique and buffers needed to produce competent cells. There are even kits available that include pre-made buffers to expedite this process. Furthermore, it is more expensive to use electroporation.
A specialized apparatus is required to implement the charge, in addition to cuvettes to transport the charge to the cell solution. Excess salt in the cuvette can cause electroporation to fail and result in the loss of valuable samples. The most widely mentioned disadvantage of chemical transformation is its reduced efficiency.
Growing Investment in Gene Cell Therapy Products to Boost the Demand
The USA dominated the North American competent cells market and accounted for nearly 84.8% in 2021. Demand in the market is anticipated to surge on the back of rising investment in gene therapy products. Further, increasing research and development by government bodies, grants, and clinical trials for disease treatment and others, will improve the growth of the competent cells market.
China Competent Cells Market to Benefit from Rising Research & Development for Cloning Efficiency
China held approximately 54.2% share in the East Asia competent cells market in 2021. Demand for competent cells in China will rise at a CAGR of 10.1% during the forecast period. Increasing research activities and grants will propel the competent cells market.
For instance, the Natural Science Foundation of China, the funding by the State Key Laboratory of Microbial Application, and the Qilu Youth Scholar Start-up Funding of SDU, funded a research study on Escherichia coli BW25113 competent cells prepared using a simple chemical method having unmatched transformation and cloning efficiencies, in 2022.
Introduction of Different Strains for Gene Transformation to Propel Sales
As per FMI, the overall sales in the German competent cells market are projected to expand at 9.3% CAGR in the Europe competent cells market during the forecast period. Increasing production activities by manufacturers to develop different types of strains, which allows easy gene transformation, will propel the market. For instance, New England Biolabs GmbH has products specific to cloning & subcloning and strains for protein expression, with each type having quality specifications.
Nearly 7 out of 10 Sales to be Contributed by Chemically Competent Cells
Chemically competent cells are expected to present high growth at a CAGR of 15.3% between 2022 and 2032, with a share of about 67.8% in 2021. Cloning, DNA sequencing, and the creation of DNA libraries are just a few of the many molecular biology techniques that frequently include transformation. Competent cells must be used to perform the transformation. Chemically competent cells hold a bigger market share because chemical transformation is quicker and less error-prone than electroporation.
Cloning Segment to Account for Around 3/5th of Competent Cells Sales
In terms of application, the cloning segment held a revenue share of 57.8% in 2021 and is expected to display steady growth over the forecast period. Competent cells are frequently employed in molecular cloning to increase and preserve cloned DNA in plasmids because they are engineered to absorb foreign DNA from the environment more efficiently. With growing investments in cell and gene therapy, the cloning segment holds a higher market share in terms of application within the overall competent cells market, globally.
Based on end users, the academic research institutes held the highest market share value of 51.2% in 2021. Increasing research and development activities in life sciences are propelling sales of the overall competent cells market.
With several competitors in the competent cells market, the overall market is fragmented. To expand their customer base, leading companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
For instance:
| Attribute | Details |
|---|---|
| Estimated Market Size 2022 | USD 2.1 Billion |
| Projected Market Value 2032 | USD 5.9 Billion |
| CAGR 2022 to 2032 | 11.1% |
| Forecast Period | 2017 to 2021 |
| Historical Data Available for | 2022 to 2032 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Agilent Technologies Inc.; Genescript Biotech Corporation; Bio-Rad Laboratories Inc; Merck & Co Inc; OriGene Technologies, Inc; New England Biolabs Inc; Illumina, Inc.; Thermo Fisher Scientific, Inc.,; QIAGEN N.V.,; Zymo Research Corporation; Promega Corporation; HiMedia Laboratories; Avantor, Inc.; Scarab Genomics, LLC; Lucigen; bluebird bio, Inc.; Tonbo Biosciences; TransGen Biotech; Codex DNA, Inc. |
Table 01: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 02: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 03: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 04: Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region
Table 05: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 07: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 08: North America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 09: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 10: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 11: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 12: Latin America Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 13: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 14: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 15: Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 16: Europe Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 17: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 18: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 19: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 20: East Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 21: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 22: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 23: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application
Table 24: South Asia Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 25: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 26: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 27: Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032 by Application
Table 28: Oceania Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Table 29: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Country
Table 30: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product
Table 31: Middle East & Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032by Application
Table 32: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2021
Figure 02: ;Global Market Forecast & Y-o-Y Growth, 2022 to 2032
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2032
Figure 04: Global Market Value Share (%) Analysis 2022 and 2032, by Product
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Product
Figure 06: Global Market Attractiveness Analysis 2022 to 2032, by Product
Figure 07: Global Market Value Share (%) Analysis 2022 and 2032, by Application
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Application
Figure 09: Global Market Attractiveness Analysis 2022 to 2032, by Application
Figure 10: Global Market Value Share (%) Analysis 2022 and 2032, by End User
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by End User
Figure 12: Global Market Attractiveness Analysis 2022 to 2032, by End User
Figure 13: Global Market Value Share (%) Analysis 2022 and 2032, by Region
Figure 14: Global Market Y-o-Y Growth (%) Analysis 2022 to 2032, by Region
Figure 15: Global Market Attractiveness Analysis 2022 to 2032, by Region
Figure 16: North America Market Value (US$ Million) Analysis, 2017 to 2021
Figure 17: North America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 18: North America Market Value Share, by Product (2022 E)
Figure 19: North America Market Value Share, by Application (2022 E)
Figure 20: North America Market Value Share, by End User (2022 E)
Figure 21: North America Market Value Share, by Country (2022 E)
Figure 22: North America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 23: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 24: North America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 25: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 26: USA Market Value Proportion Analysis, 2021
Figure 27: Global Vs USA Growth Comparison
Figure 28: USA Market Share Analysis (%) by Product, 2021 to 2032
Figure 29: USA Market Share Analysis (%) by Application, 2021 to 2032
Figure 30: USA Market Share Analysis (%) by End User, 2021 to 2032
Figure 31: Canada Market Value Proportion Analysis, 2021
Figure 32: Global Vs. Canada. Growth Comparison
Figure 33: Canada Market Share Analysis (%) by Product, 2021 to 2032
Figure 34: Canada Market Share Analysis (%) by Application, 2021 to 2032
Figure 35: Canada Market Share Analysis (%) by End User, 2021 to 2032
Figure 36: Latin America Market Value (US$ Million) Analysis, 2017 to 2021
Figure 37: Latin America Market Value (US$ Million) Forecast, 2022 to 2032
Figure 38: Latin America Market Value Share, by Product (2022 E)
Figure 39: Latin America Market Value Share, by Application (2022 E)
Figure 40: Latin America Market Value Share, by End User (2022 E)
Figure 41: Latin America Market Value Share, by Country (2022 E)
Figure 42: Latin America Market Attractiveness Analysis by Product, 2022 to 2032
Figure 43: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 44: Latin America Market Attractiveness Analysis by End User, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 46: Mexico Market Value Proportion Analysis, 2021
Figure 47: Global Vs Mexico Growth Comparison
Figure 48: Mexico Market Share Analysis (%) by Product, 2021 to 2032
Figure 49: Mexico Market Share Analysis (%) by Application, 2021 to 2032
Figure 50: Mexico Market Share Analysis (%) by End User, 2021 to 2032
Figure 51: Brazil Market Value Proportion Analysis, 2021
Figure 52: Global Vs. Brazil. Growth Comparison
Figure 53: Brazil Market Share Analysis (%) by Product, 2021 to 2032
Figure 54: Brazil Market Share Analysis (%) by Application, 2021 to 2032
Figure 55: Brazil Market Share Analysis (%) by End User, 2021 to 2032
Figure 56: Argentina Market Value Proportion Analysis, 2021
Figure 57: Global Vs Argentina Growth Comparison
Figure 58: Argentina Market Share Analysis (%) by Product, 2021 to 2032
Figure 59: Argentina Market Share Analysis (%) by Application, 2021 to 2032
Figure 60: Argentina Market Share Analysis (%) by End User, 2021 to 2032
Figure 61: Europe Market Value (US$ Million) Analysis, 2017 to 2021
Figure 62: Europe Market Value (US$ Million) Forecast, 2022 to 2032
Figure 63: Europe Market Value Share, by Product (2022 E)
Figure 64: Europe Market Value Share, by Application (2022 E)
Figure 65: Europe Market Value Share, by End User (2022 E)
Figure 66: Europe Market Value Share, by Country (2022 E)
Figure 67: Europe Market Attractiveness Analysis by Product, 2022 to 2032
Figure 68: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 69: Europe Market Attractiveness Analysis by End User, 2022 to 2032
Figure 70: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 71: UK Market Value Proportion Analysis, 2021
Figure 72: Global Vs. UK Growth Comparison
Figure 73: UK Market Share Analysis (%) by Product, 2021 to 2032
Figure 74: UK Market Share Analysis (%) by Application, 2021 to 2032
Figure 75: UK Market Share Analysis (%) by End User, 2021 to 2032
Figure 76: Germany Market Value Proportion Analysis, 2021
Figure 77: Global Vs. Germany Growth Comparison
Figure 78: Germany Market Share Analysis (%) by Product, 2021 to 2032
Figure 79: Germany Market Share Analysis (%) by Application, 2021 to 2032
Figure 80: Germany Market Share Analysis (%) by End User, 2021 to 2032
Figure 81: Italy Market Value Proportion Analysis, 2021
Figure 82: Global Vs. Italy Growth Comparison
Figure 83: Italy Market Share Analysis (%) by Product, 2021 to 2032
Figure 84: Italy Market Share Analysis (%) by Application, 2021 to 2032
Figure 85: Italy Market Share Analysis (%) by End User, 2021 to 2032
Figure 86: France Market Value Proportion Analysis, 2021
Figure 87: Global Vs France Growth Comparison
Figure 88: France Market Share Analysis (%) by Product, 2021 to 2032
Figure 89: France Market Share Analysis (%) by Application, 2021 to 2032
Figure 90: France Market Share Analysis (%) by End User, 2021 to 2032
Figure 91: Spain Market Value Proportion Analysis, 2021
Figure 92: Global Vs Spain Growth Comparison
Figure 93: Spain Market Share Analysis (%) by Product, 2021 to 2032
Figure 94: Spain Market Share Analysis (%) by Application, 2021 to 2032
Figure 95: Spain Market Share Analysis (%) by End User, 2021 to 2032
Figure 96: Russia Market Value Proportion Analysis, 2021
Figure 97: Global Vs Russia Growth Comparison
Figure 98: Russia Market Share Analysis (%) by Product, 2021 to 2032
Figure 99: Russia Market Share Analysis (%) by Application, 2021 to 2032
Figure 100: Russia Market Share Analysis (%) by End User, 2021 to 2032
Figure 101: BENELUX Market Value Proportion Analysis, 2021
Figure 102: Global Vs BENELUX Growth Comparison
Figure 103: BENELUX Market Share Analysis (%) by Product, 2021 to 2032
Figure 104: BENELUX Market Share Analysis (%) by Application, 2021 to 2032
Figure 105: BENELUX Market Share Analysis (%) by End User, 2021 to 2032
Figure 106: East Asia Market Value (US$ Million) Analysis, 2017 to 2021
Figure 107: East Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 108: East Asia Market Value Share, by Product (2022 E)
Figure 109: East Asia Market Value Share, by Application (2022 E)
Figure 110: East Asia Market Value Share, by End User (2022 E)
Figure 111: East Asia Market Value Share, by Country (2022 E)
Figure 112: East Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 113: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 114: East Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 115: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 116: China Market Value Proportion Analysis, 2021
Figure 117: Global Vs. China Growth Comparison
Figure 118: China Market Share Analysis (%) by Product, 2021 to 2032
Figure 119: China Market Share Analysis (%) by Application, 2021 to 2032
Figure 120: China Market Share Analysis (%) by End User, 2021 to 2032
Figure 121: Japan Market Value Proportion Analysis, 2021
Figure 122: Global Vs. Japan Growth Comparison
Figure 123: Japan Market Share Analysis (%) by Product, 2021 to 2032
Figure 124: Japan Market Share Analysis (%) by Application, 2021 to 2032
Figure 125: Japan Market Share Analysis (%) by End User, 2021 to 2032
Figure 126: South Korea Market Value Proportion Analysis, 2021
Figure 127: Global Vs South Korea Growth Comparison
Figure 128: South Korea Market Share Analysis (%) by Product, 2021 to 2032
Figure 129: South Korea Market Share Analysis (%) by Application, 2021 to 2032
Figure 130: South Korea Market Share Analysis (%) by End User, 2021 to 2032
Figure 131: South Asia Market Value (US$ Million) Analysis, 2017 to 2021
Figure 132: South Asia Market Value (US$ Million) Forecast, 2022 to 2032
Figure 133: South Asia Market Value Share, by Product (2022 E)
Figure 134: South Asia Market Value Share, by Application (2022 E)
Figure 135: South Asia Market Value Share, by End User (2022 E)
Figure 136: South Asia Market Value Share, by Country (2022 E)
Figure 137: South Asia Market Attractiveness Analysis by Product, 2022 to 2032
Figure 138: South Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 139: South Asia Market Attractiveness Analysis by End User, 2022 to 2032
Figure 140: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 141: India Market Value Proportion Analysis, 2021
Figure 142: Global Vs. India Growth Comparison
Figure 143: India Market Share Analysis (%) by Product, 2021 to 2032
Figure 144: India Market Share Analysis (%) by Application, 2021 to 2032
Figure 145: India Market Share Analysis (%) by End User, 2021 to 2032
Figure 146: Indonesia Market Value Proportion Analysis, 2021
Figure 147: Global Vs. Indonesia Growth Comparison
Figure 148: Indonesia Market Share Analysis (%) by Product, 2021 to 2032
Figure 149: Indonesia Market Share Analysis (%) by Application, 2021 to 2032
Figure 150: Indonesia Market Share Analysis (%) by End User, 2021 to 2032
Figure 151: Malaysia Market Value Proportion Analysis, 2021
Figure 152: Global Vs. Malaysia Growth Comparison
Figure 153: Malaysia Market Share Analysis (%) by Product, 2021 to 2032
Figure 154: Malaysia Market Share Analysis (%) by Application, 2021 to 2032
Figure 155: Malaysia Market Share Analysis (%) by End User, 2021 to 2032
Figure 156: Thailand Market Value Proportion Analysis, 2021
Figure 157: Global Vs. Thailand Growth Comparison
Figure 158: Thailand Market Share Analysis (%) by Product, 2021 to 2032
Figure 159: Thailand Market Share Analysis (%) by Application, 2021 to 2032
Figure 160: Thailand Market Share Analysis (%) by End User, 2021 to 2032
Figure 161: Oceania Market Value (US$ Million) Analysis, 2017 to 2021
Figure 162: Oceania Market Value (US$ Million) Forecast, 2022 to 2032
Figure 163: Oceania Market Value Share, by Product (2022 E)
Figure 164: Oceania Market Value Share, by Application (2022 E)
Figure 165: Oceania Market Value Share, by End User (2022 E)
Figure 166: Oceania Market Value Share, by Country (2022 E)
Figure 167: Oceania Market Attractiveness Analysis by Product, 2022 to 2032
Figure 168: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 169: Oceania Market Attractiveness Analysis by End User, 2022 to 2032
Figure 170: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 171: Australia Market Value Proportion Analysis, 2021
Figure 172: Global Vs. Australia Growth Comparison
Figure 173: Australia Market Share Analysis (%) by Product, 2021 to 2032
Figure 174: Australia Market Share Analysis (%) by Application, 2021 to 2032
Figure 175: Australia Market Share Analysis (%) by End User, 2021 to 2032
Figure 176: New Zealand Market Value Proportion Analysis, 2021
Figure 177: Global Vs New Zealand Growth Comparison
Figure 178: New Zealand Market Share Analysis (%) by Product, 2021 to 2032
Figure 179: New Zealand Market Share Analysis (%) by Application, 2021 to 2032
Figure 180: New Zealand Market Share Analysis (%) by End User, 2021 to 2032
Figure 181: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2021
Figure 182: Middle East & Africa Market Value (US$ Million) Forecast, 2022 to 2032
Figure 183: Middle East & Africa Market Value Share, by Product (2022 E)
Figure 184: Middle East & Africa Market Value Share, by Application (2022 E)
Figure 185: Middle East & Africa Market Value Share, by End User (2022 E)
Figure 186: Middle East & Africa Market Value Share, by Country (2022 E)
Figure 187: Middle East & Africa Market Attractiveness Analysis by Product, 2022 to 2032
Figure 188: Middle East & Africa Market Attractiveness Analysis by Application, 2022 to 2032
Figure 189: Middle East & Africa Market Attractiveness Analysis by End User, 2022 to 2032
Figure 190: Middle East & Africa Market Attractiveness Analysis by Country, 2022 to 2032
Figure 191: GCC Countries Market Value Proportion Analysis, 2021
Figure 192: Global Vs GCC Countries Growth Comparison
Figure 193: GCC Countries Market Share Analysis (%) by Product, 2021 to 2032
Figure 194: GCC Countries Market Share Analysis (%) by Application, 2021 to 2032
Figure 195: GCC Countries Market Share Analysis (%) by End User, 2021 to 2032
Figure 196: Turkey Market Value Proportion Analysis, 2021
Figure 197: Global Vs. Turkey Growth Comparison
Figure 198: Turkey Market Share Analysis (%) by Product, 2021 to 2032
Figure 199: Turkey Market Share Analysis (%) by Application, 2021 to 2032
Figure 200: Turkey Market Share Analysis (%) by End User, 2021 to 2032
Figure 201: South Africa Market Value Proportion Analysis, 2021
Figure 202: Global Vs. South Africa Growth Comparison
Figure 203: South Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 204: South Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 205: South Africa Market Share Analysis (%) by End User, 2021 to 2032
Figure 206: North Africa Market Value Proportion Analysis, 2021
Figure 207: Global Vs North Africa Growth Comparison
Figure 208: North Africa Market Share Analysis (%) by Product, 2021 to 2032
Figure 209: North Africa Market Share Analysis (%) by Application, 2021 to 2032
Figure 210: North Africa Market Share Analysis (%) by End User, 2021 to 2032
The global competent cells market is worth USD 1.9 Billion in 2021 and is set to expand by 2.9X over the next ten years.
The competent cells market is expected to reach USD 5.9 Billion by the end of 2032, with sales revenue expected to register an 11.1% CAGR.
The growing prevalence of genetic disorders and increasing research and developments are some of the key trends in this market.
The USA, India, China, Germany, and Japan are expected to drive demand for the competent cells industry.
North America is expected to lead the growth in the competent cells market, with the USA accounting for about 84.8% of the share in 2021.
Demand for competent cells in Europe is expected to register a growth of 10.9% over the next ten years.
Demand for competent cells in Latin America is expected to register a growth at 10.6% CAGR over the next ten years
Demand for competent cells in MEA is expected to register a growth of 8.7% over the next ten years
China, the USA, and Germany are the key producers of competent cells.
Explore Similar Insights
Competent Cells Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
